NCT00819169 2024-08-20QUILT-3.026: AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid TumorsNantCell, Inc.Phase 1/2 Terminated89 enrolled 20 charts
NCT04129151 2024-08-01Palbociclib + Ganitumab In Ewing SarcomaDana-Farber Cancer InstitutePhase 2 Terminated10 enrolled 15 charts
NCT01327612 2021-02-21Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)AmgenPhase 2 Completed12 enrolled 21 charts
NCT00562380 2013-07-18AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin LymphomaNational Cancer Institute (NCI)Phase 1 Completed64 enrolled